Back to results
US 2020/0347050 A1Published application
Tetrahydropyrazolopyrimidine compounds
AssigneeEisai R&D Management Co., Ltd.
InventorsRoch BOIVIN, Eric CARLSON, Atsushi ENDO, Hans HANSEN, Lynn D. HAWKINS, Sally ISHIZAKA, Matthew MACKEY, Sridhar NARAYAN, Takashi SATOH, Shawn SCHILLER
Life of this patent
Estimating the term…
Abstract
Embodiments of the disclosure relate to tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.
Claims16
1-48. (canceled)
A method of preparing a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof or mixture of stereoisomers thereof, wherein
- R1 is optionally substituted piperidinyl, optionally substituted pyridyl, optionally substituted pyrrolyl, optionally substituted pyrroldinyl, 1,4-dimethylthiazolyl, 2-ethyl-4-methylthiazolyl, 2-isopropylthiazol-5-yl, thiazolyl, 3-ethylthiazol-5-yl, 1-methylsulfonylpiperidin-4-yl, or
- R1 is —C(O)Z, where Z is piperazinyl, (S)-2-(3-ethylpiperazin-1-yl), optionally substituted pyrrolopyrrolyl, piperidin-3-ylamino, or,
- R1 is
- where R13 is H, methylpyrazolyl, methylimidazolyl, benzyl, 3-hydroxybutyl, 3-(dimethylamino)-2,2-dimethylpropyl, ethylamide, methylpyridyl, methylsulfonyl, (1-methylimidazol-2-yl)methyl, (1,5-dimethylimidazol-4-yl)methyl, (1-methylpyrrol-2-yl)methyl, or where R13 is C(O)W, where W is —N(CH3)2, piperidinyl, piperazinyl, or morpholinyl, or,
- R1 is
- where R14 is —C(O)CH3, H or (1-methylpyrrol-2-yl)methyl, or,
- R1 is
- R1 is
- where A, B, and D may all be carbon, or where two of A, B, and D are carbon and the other is nitrogen, or where one of A, B, and D is carbon and the remaining two are nitrogen;
- and when A is nitrogen R4 is absent, when B is nitrogen R2 is absent, and when D is nitrogen R3 is absent;
- and wherein
- R2 is H, —CH3, or F, or, with R3 and the atoms at positions a and b, forms an optionally substituted pyridine or a pyrazole;
- and wherein
- R3 is H, F, Cl, —CN, —CH3, —OCH3, —OH, —NH2, methylsulfonyl,
- or, with R4 and the atoms at b and c, forms an optionally substituted benzene, optionally substituted imidazole, optionally substituted pyrazole, optionally substituted pyrazolidine, optionally substituted imidazolidine, optionally substituted isothiazole,
- or, with R2 and the atoms at a and b, forms an optionally substituted pyridine or optionally substituted pyrazole;
- and wherein
- R4 is F, —CN, —OCH3, —OEt, H, Cl, Br, —NH—C(O)—CH—(CH3)2, —N(CH3)2, —CH3, —CH2OH,
- optionally substituted piperazinyl, 4-hydroxypiperizin-1-yl, optionally substituted piperidinyl not attached to a phenyl group through a nitrogen, or, with R3 and the atoms at b and c, forms an optionally substituted pyrazole ring or
- or, with R5 and the atoms at c and d, forms an optionally substituted pyrazole ring or an optionally substituted pyrrole ring, or,
- R4 is -(q)-C(O)X, where q is a bond, is —NH—, or is —CH2—, and
- where X is —NR11R12,
- where R11 and R12 are both H, both —CH2CH3, or both —CH3, or where one of R11 and R12 is H and the other is 1,1-dimethylethyl, cyclobutyl, cyclopropyl, lower alkyl, methyl alcohol, propyl alcohol, cyclobutylmethyl;
- 2,3-dihydroxypropyl, benzyl, azetidinyl, pyrrolidinyl, piperidinyl, methylazetidinyl, —CH2—NH—CH3, pyrazolyl, piperazinyl, alcohol, —OCH3, or
- or
- where X is optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperidinyl not attached through a nitrogen to the carbonyl group of R4, optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperazinyl attached through a nitrogen to the carbonyl group of R4, or optionally substituted morpholinyl attached through a nitrogen to the carbonyl group of R4,
- and wherein
- R5 is H, F, Cl, —CH3, —OCH3, pyrrolyl, —CH2OH, —NH2, —OH,
- or, with R4 and the atoms at c and d, forms an optionally substituted benzene, an optionally substituted pyrazole, or an optionally substituted pyrrole, or, with R6 and the atoms at d and e, forms an optionally substituted pyridine, or R5 is C(O)Y, where Y is —NH2, —N(CH3)2, optionally substituted piperazinyl, optionally substituted piperidinyl,
- and wherein
- R6 is H, F, —CH3, —CF3, or, with R5 and the atoms at c and d, forms an optionally substituted benzene or an optionally substituted pyrazole;
- and wherein
- R7 is —CF3 or —CHF2;
- and wherein
- R8 is
- and wherein
- R9 is Br, Cl, F, I, or H;
- with the following provisos:
- when R4 is F:
- R2 is not —CH3 or F;
- R3 is not —CH3, —CN, F, Cl, or —OCH3;
- R5 is not —CH3, F, Cl, or —OCH3;
- and R6 is not —CH3 or F;
- when R4 is Cl:
- R2 is not F;
- R3 is not F or —CN;
- R5 is not F, —CN, or —C(O)N(CH3)2, R6 is not —CF3 or F;
- D is not nitrogen;
- and either R5 is —C(O)NH2 or one of R2, R3, R5, and R6 is —CH3;
- when R4 is —CH3:
- R3 is not F;
- R5 is not F;
- and R5 and R6 do not form a pyrimidine together with the atoms at d and e;
- when R4 is —OCH3:
- R2 is not F;
- R3 is not Cl or —OCH3, R5 is not Cl or —OCH3;
- and R6 is not F or —CF3;
- when R4 is —CN:
- R2 is not F;
- R3 is not Cl, F, or —OCH3, R5 is not Cl, F, or —OCH3;
- and R6 is not F;
- when R4 is —OCH2CH3:
- R3 is not Cl or F;
- R5 is not Cl or F;
- and R6 is not —CF3;
- when R4 is
- R3 is not H or F;
- and R5 is not H or F;
- when R4 is
- at least one of R2, R3, R5, and R6 is not H;
- when R4 is
- R3 is not F;
- and R5 is not F;
- when R2 is F:
- R3 is not —OCH3 or F;
- R5 is not —CN;
- and at least one of R3, R4, R5, and R6 is not H;
- when R2 is Cl:
- R3 is not F;
- when R2 is —CH3:
- R3 is not Cl;
- at least one of R3, R4, R5, and R6 is not —CH3;
- and R4 and R5 do not form a pyrazolyl with the atoms at c and d;
- when R3 is —OCH3:
- R2 is not F;
- and R6 is not F;
- when R3 is F:
- R2 is not —OCH3;
- and X is not
- when R3 is Cl:
- R5 is not Cl;
- R11 is not benzyl;
- and R12 is not benzyl;
- when R5 is Cl, R6 is not —CH3;
- R11 is not benzyl;
- and R12 is not benzyl;
- when R5 is F or —OCH3:
- R6 is not F;
- when R6 is F:
- at least one of R2, R3, R4, and R5 is not H;
- when R3 and R5 are H:
- R11 is not cyclopropyl;
- and R12 is not cyclopropyl;
- when R9 is Cl, R1 is not an amide group;
- when B is nitrogen and A and D are carbon:
- R4 may not be —CN or
- when R7 is —CHF2 and R4 is
- then R4 does not have the absolute stereochemistry
- and
- wherein, when R8 is
- then the following provisos are in effect:
- when R4 is F:
- at least one of R2, R3, R5, and R6 is not H;
- R3 is not C(O)N(CH3)2;
- and R5 is not C(O)N(CH3)2;
- when R4 is Cl:
- at least one of R2, R3, R5, and R6 is not H;
- when R3 is F:
- R4 is not C(O)NHCH2CH2CH2CH3, C(O)N(CH3)2, C(O)NHCH2CH2CH3, or C(O)NHC(CH3)3;
- R4 is not C(O)NHCH2CH2CH2OH, C(O)NHCH(CH3)2, —CN, or
- R1 is not
- R5 is not
- R3 is not
- when R2 is F:
- R5 is not —C(O)NH2;
- when R2 is —CH3, R4 and R5 do not form a pyrazole with atoms at c and d;
- and
- when B is nitrogen, R3 and R4 do not form an optionally substituted imidazole with the atoms at b and c;
- and
- wherein, when R8 is
- then following provisos are in effect:
- R4 is not —CH3, —C(O)NHCH2CH2OH, —NHC(O)CH(CH3)2, or
- when R4 is C(O)NHCH3, at least one of R2, R3, R5, and R6 is not H;
- when R4 is —OCH3:
- R3 is not F or —CH3;
- and R5 is not F or —CH3;
- when R4 is
- R3 is not Cl;
- and R5 is not Cl;
- when R4 is —C(O)NHCH(CH3)2 or —C(O)N(CH2CH3)2:
- at least one of R3 and R5 is not H;
- R5 is not —C(O)NH2;
- and
- R6 is not —CF3, comprising:
- condensing a compound of formula III
- and a compound of formula VI
- in the presence of an organic acid to form a compound of formula VII
- and reducing a compound of formula VII to form a compound of formula (I).
146 more elements
A method of preparing a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof or mixture of stereoisomers thereof, wherein
- R1 is optionally substituted piperidinyl, optionally substituted pyridyl, optionally substituted pyrrolyl, optionally substituted pyrroldinyl, 1,4-dimethylthiazolyl, 2-ethyl-4-methylthiazolyl, 2-isopropylthiazol-5-yl, thiazolyl, 3-ethylthiazol-5-yl, 1-methylsulfonylpiperidin-4-yl, or
- R1 is —C(O)Z, where Z is piperazinyl, (S)-2-(3-ethylpiperazin-1-yl), optionally substituted pyrrolopyrrolyl, piperidin-3-ylamino, or,
- R1 is
- where R13 is H, methylpyrazolyl, methylimidazolyl, benzyl, 3-hydroxybutyl, 3-(dimethylamino)-2,2-dimethylpropyl, ethylamide, methylpyridyl, methylsulfonyl, (1-methylimidazol-2-yl)methyl, (1,5-dimethylimidazol-4-yl)methyl, (1-methylpyrrol-2-yl)methyl, or where R13 is C(O)W, where W is —N(CH3)2, piperidinyl, piperazinyl, or morpholinyl, or,
- R1 is
- where R14 is —C(O)CH3, H, or (1-methylpyrrol-2-yl)methyl, or,
- R1 is
- R1 is
- where A, B, and D may all be carbon, or where two of A, B, and D are carbon and the other is nitrogen, or where one of A, B, and D is carbon and the remaining two are nitrogen;
- and when A is nitrogen R4 is absent, when B is nitrogen R2 is absent, and when D is nitrogen R3 is absent;
- and wherein
- R2 is H, —CH3, or F, or, with R3 and the atoms at positions a and b, forms an optionally substituted pyridine or a pyrazole;
- and wherein
- R3 is H, F, Cl, —CN, —CH3, —OCH3, —OH, —NH2, methylsulfonyl,
- or, with R4 and the atoms at b and c, forms an optionally substituted benzene, optionally substituted imidazole, optionally substituted pyrazole, optionally substituted pyrazolidine, optionally substituted imidazolidine, optionally substituted isothiazole,
- or, with R2 and the atoms at a and b, forms an optionally substituted pyridine or optionally substituted pyrazole;
- and wherein
- R4 is F, —CN, —OCH3, —OEt, H, Cl, Br, —NH—C(O)—CH—(CH3)2, —N(CH3)2, —CH3, —CH2OH,
- optionally substituted piperazinyl, 4-hydroxypiperizin-1-yl, optionally substituted piperidinyl not attached to a phenyl group through a nitrogen, or, with R3 and the atoms at b and c, forms
- an optionally substituted pyrazole ring or
- or, with R5 and the atoms at c and d, forms an optionally substituted pyrazole ring or an optionally substituted pyrrole ring, or,
- R4 is -(q)-C(O)X, where q is a bond, is —NH—, or is —CH2—, and
- where X is —NR11R12,
- where R11 and R12 are both H, both —CH2CH3, or both —CH3, or where one of R11 and R12 is H and the other is 1,1-dimethylethyl, cyclobutyl, cyclopropyl, lower alkyl, methyl alcohol, propyl alcohol, cyclobutylmethyl;
- 2,3-dihydroxypropyl, benzyl, azetidinyl, pyrrolidinyl, piperidinyl, methylazetidinyl, —CH2—NH—CH3, pyrazolyl, piperazinyl, alcohol, —OCH3, or
- or
- where X is optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperidinyl not attached through a nitrogen to the carbonyl group of R4, optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperazinyl attached through a nitrogen to the carbonyl group of R4, or optionally substituted morpholinyl attached through a nitrogen to the carbonyl group of R4,
- and wherein
- R5 is H, F, Cl, —CH3, —OCH3, pyrrolyl, —CH2OH, —NH2, —OH,
- or, with R4 and the atoms at c and d, forms an optionally substituted benzene, an optionally substituted pyrazole, or an optionally substituted pyrrole, or, with R6 and the atoms at d and e, forms an optionally substituted pyridine, or R5 is C(O)Y, where Y is —NH2, —N(CH3)2, optionally substituted piperazinyl, optionally substituted piperidinyl,
- and wherein
- R6 is H, F, —CH3, —CF3, or, with R5 and the atoms at c and d, forms an optionally substituted benzene or an optionally substituted pyrazole;
- and wherein
- R7 is —CF3 or —CHF2;
- and wherein
- R8 is
- and wherein
- R9 is Br, Cl, F, I, or H;
- with the following provisos:
- when R4 is F:
- R2 is not —CH3 or F;
- R3 is not —CH3, —CN, F, Cl, or —OCH3;
- R5 is not —CH3, F, Cl, or —OCH3;
- and R6 is not —CH3 or F;
- when R4 is Cl:
- R2 is not F;
- R3 is not F or —CN;
- R5 is not F, —CN, or —C(O)N(CH3)2, R6 is not —CF3 or F;
- D is not nitrogen;
- and either R5 is —C(O)NH2 or one of R2, R3, R5, and R6 is —CH3;
- when R4 is —CH3:
- R3 is not F;
- R5 is not F;
- and R5 and R6 do not form a pyrimidine together with the atoms at d and e;
- when R4 is —OCH3:
- R2 is not F;
- R3 is not Cl or —OCH3, R5 is not Cl or —OCH3;
- and R6 is not F or —CF3;
- when R4 is —CN:
- R2 is not F;
- R3 is not Cl, F, or —OCH3, R5 is not Cl, F, or —OCH3;
- and R6 is not F;
- when R4 is —OCH2CH3:
- R3 is not Cl or F;
- R5 is not Cl or F;
- and R6 is not —CF3;
- when R4 is
- R3 is not H or F;
- and R5 is not H or F;
- when R4 is
- at least one of R2, R3, R5, and R6 is not H;
- when R4 is
- R3 is not F;
- and R5 is not F;
- when R2 is F:
- R3 is not —OCH3 or F;
- R5 is not —CN;
- and at least one of R3, R4, R5, and R6 is not H;
- when R2 is Cl:
- R3 is not F;
- when R2 is —CH3:
- R3 is not Cl;
- at least one of R3, R4, R5, and R6 is not —CH3;
- and R4 and R5 do not form a pyrazolyl with the atoms at c and d;
- when R3 is —OCH3:
- R2 is not F;
- and R6 is not F;
- when R3 is F:
- R2 is not —OCH3;
- and X is not;
- when R3 is Cl:
- R5 is not Cl;
- R is not benzyl;
- and R12 is not benzyl;
- when R5 is Cl, R6 is not —CH3;
- R is not benzyl;
- and R12 is not benzyl;
- when R5 is F or —OCH3:
- R6 is not F;
- when R6 is F:
- at least one of R2, R3, R4, and R5 is not H;
- when R3 and R5 are H:
- R11 is not cyclopropyl;
- and R12 is not cyclopropyl;
- when R9 is Cl, R1 is not an amide group;
- when B is nitrogen and A and D are carbon:
- R4 may not be —CN or
- when R7 is —CHF2 and R4 is
- then R4 does not have the absolute stereochemistry
- and
- wherein, when R8 is
- then the following provisos are in effect:
- when R4 is F:
- at least one of R2, R3, R5, and R6 is not H;
- R3 is not C(O)N(CH3)2;
- and R5 is not C(O)N(CH3)2;
- when R4 is Cl:
- at least one of R2, R3, R5, and R6 is not H;
- when R3 is F:
- R4 is not C(O)NHCH2CH2CH2CH3, C(O)N(CH3)2, C(O)NHCH2CH2CH3, or C(O)NHC(CH3)3;
- R4 is not C(O)NHCH2CH2CH2OH, C(O)NHCH(CH3)2, —CN, or
- R1 is not
- R5 is not
- R3 is not;
- when R2 is F:
- R5 is not —C(O)NH2;
- when R2 is —CH3, R4 and R5 do not form a pyrazole with atoms at c and d;
- and
- when B is nitrogen, R3 and R4 do not form an optionally substituted imidazole with the atoms at b and c;
- and
- wherein, when R8 is
- then following provisos are in effect:
- R4 is not —CH3, —C(O)NHCH2CH2OH, —NHC(O)CH(CH3)2, or
- when R4 is C(O)NHCH3, at least one of R2, R3, R5, and R6 is not H;
- when R4 is —OCH3:
- R3 is not F or —CH3;
- and R5 is not F or —CH3;
- when R4 is
- R3 is not Cl;
- and R5 is not Cl;
- when R4 is —C(O)NHCH(CH3)2 or —C(O)N(CH2CH3)2:
- at least one of R3 and R5 is not H;
- R5 is not —C(O)NH2;
- and
- R6 is not —CF3, comprising:
- condensing a compound of formula IV
- and a compound of formula VI
- to form a compound of formula X
- reacting a compound of formula X with a triflouromethylsulfonylation reagent to provide a compound of formula XI
- and
- (1) reducing a compound of formula XI to form a compound of formula XII
- and subjecting a compound a formula XII to Suzuki cross-coupling conditions with a boronate
- to form a compound of formula (I);
- or
- (2) subjecting a compound of formula XI to Suzuki cross-coupling conditions with a boronate
- to form a compound of formula XIV
- and reducing a compound of formula XIV to form a compound of formula (I).
155 more elements
A method of preparing a compound of formula (I)
- or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof or mixture of stereoisomers thereof, wherein
- R1 is optionally substituted piperidinyl, optionally substituted pyridyl, optionally substituted pyrrolyl, optionally substituted pyrroldinyl, 1,4-dimethylthiazolyl, 2-ethyl-4-methylthiazolyl, 2-isopropylthiazol-5-yl, thiazolyl, 3-ethylthiazol-5-yl, 1-methylsulfonylpiperidin-4-yl, or
- R1 is —C(O)Z, where Z is piperazinyl, (S)-2-(3-ethylpiperazin-1-yl), optionally substituted pyrrolopyrrolyl, piperidin-3-ylamino, or,
- R1 is
- where R13 is H, methylpyrazolyl, methylimidazolyl, benzyl, 3-hydroxybutyl, 3-(dimethylamino)-2,2-dimethylpropyl, ethylamide, methylpyridyl, methylsulfonyl, (1-methylimidazol-2-yl)methyl, (1,5-dimethylimidazol-4-yl)methyl, (1-methylpyrrol-2-yl)methyl, or where R13 is C(O)W, where W is —N(CH3)2, piperidinyl, piperazinyl, or morpholinyl, or,
- R1 is
- where R14 is —C(O)CH3, H, or (1-methylpyrrol-2-yl)methyl, or,
- R1 is
- or
- R1 is
- where A, B, and D may all be carbon, or where two of A, B, and D are carbon and the other is nitrogen, or where one of A, B, and D is carbon and the remaining two are nitrogen;
- and when A is nitrogen R4 is absent, when B is nitrogen R2 is absent, and when D is nitrogen R3 is absent;
- and wherein
- R2 is H, —CH3, or F, or, with R3 and the atoms at positions a and b, forms an optionally substituted pyridine or a pyrazole;
- and wherein
- R3 is H, F, Cl, —CN, —CH3, —OCH3, —OH, —NH2, methylsulfonyl,
- or, with R4 and the atoms at b and c, forms an optionally substituted benzene, optionally substituted imidazole, optionally substituted pyrazole, optionally substituted pyrazolidine, optionally substituted imidazolidine, optionally substituted isothiazole,
- or, with R2 and the atoms at a and b, forms an optionally substituted pyridine or optionally substituted pyrazole;
- and wherein
- R4 is F, —CN, —OCH3, —OEt, H, Cl, Br, —NH—C(O)—CH—(CH3)2, —N(CH3)2, —CH3, —CH2OH,
- optionally substituted piperazinyl, 4-hydroxypiperizin-1-yl, optionally substituted piperidinyl not attached to a phenyl group through a nitrogen, or, with R3 and the atoms at b and c, forms an optionally substituted pyrazole ring or
- or, with R5 and the atoms at c and d, forms an optionally substituted pyrazole ring or an optionally substituted pyrrole ring, or,
- R4 is -(q)-C(O)X, where q is a bond, is —NH—, or is —CH2—, and
- where X is —NR11R12,
- where R11 and R12 are both H, both —CH2CH3, or both —CH3, or where one of R11 and R12 is H and the other is 1,1-dimethylethyl, cyclobutyl, cyclopropyl, lower alkyl, methyl alcohol, propyl alcohol, cyclobutylmethyl;
- 2,3-dihydroxypropyl, benzyl, azetidinyl, pyrrolidinyl, piperidinyl, methylazetidinyl, —CH2—NH—CH3, pyrazolyl, piperazinyl, alcohol, —OCH3, or
- or
- where X is optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperidinyl not attached through a nitrogen to the carbonyl group of R4, optionally substituted pyrrolidinyl attached through a nitrogen to the carbonyl group of R4, optionally substituted piperazinyl attached through a nitrogen to the carbonyl group of R4, or optionally substituted morpholinyl attached through a nitrogen to the carbonyl group of R4,
- and wherein
- R5 is H, F, Cl, —CH3, —OCH3, pyrrolyl, —CH2OH, —NH2, —OH,
- or, with R4 and the atoms at c and d, forms an optionally substituted benzene, an optionally substituted pyrazole, or an optionally substituted pyrrole, or, with R6 and the atoms at d and e, forms an optionally substituted pyridine, or R5 is C(O)Y, where Y is —NH2, —N(CH3)2, optionally substituted piperazinyl, optionally substituted piperidinyl,
- and wherein
- R6 is H, F, —CH3, —CF3, or, with R5 and the atoms at c and d, forms an optionally substituted benzene or an optionally substituted pyrazole;
- and wherein
- R7 is —CF3 or —CHF2;
- and wherein
- R8 is
- and wherein
- R9 is Br, Cl, F, I, or H;
- with the following provisos:
- when R4 is F:
- R2 is not —CH3 or F;
- R3 is not —CH3, —CN, F, Cl, or —OCH3;
- R5 is not —CH3, F, Cl, or —OCH3;
- and R6 is not —CH3 or F;
- when R4 is Cl:
- R2 is not F;
- R3 is not F or —CN;
- R5 is not F, —CN, or —C(O)N(CH3)2, R6 is not —CF3 or F;
- D is not nitrogen;
- and either R5 is —C(O)NH2 or one of R2, R3, R5, and R6 is —CH3;
- when R4 is —CH3:
- R3 is not F;
- R5 is not F;
- and R5 and R6 do not form a pyrimidine together with the atoms at d and e;
- when R4 is —OCH3:
- R2 is not F;
- R3 is not Cl or —OCH3, R5 is not Cl or —OCH3;
- and R6 is not F or —CF3;
- when R4 is —CN:
- R2 is not F;
- R3 is not Cl, F, or —OCH3, R5 is not Cl, F, or —OCH3;
- and R6 is not F;
- when R4 is —OCH2CH3:
- R3 is not Cl or F;
- R5 is not Cl or F;
- and R6 is not —CF3;
- when R4 is
- R3 is not H or F;
- and R5 is not H or F;
- when R4 is
- at least one of R2, R3, R5, and R6 is not H;
- when R4 is
- R3 is not F;
- and R5 is not F;
- when R2 is F:
- R3 is not —OCH3 or F;
- R5 is not —CN;
- and at least one of R3, R4, R5, and R6 is not H;
- when R2 is Cl:
- R3 is not F;
- when R2 is —CH3:
- R3 is not Cl;
- at least one of R3, R4, R5, and R6 is not —CH3;
- and R4 and R5 do not form a pyrazolyl with the atoms at c and d;
- when R3 is —OCH3:
- R2 is not F;
- and R6 is not F;
- when R3 is F:
- R2 is not —OCH3;
- and X is not
- when R3 is Cl:
- R5 is not Cl;
- R is not benzyl;
- and R12 is not benzyl;
- when R5 is Cl, R6 is not —CH3;
- R is not benzyl;
- and R12 is not benzyl;
- when R5 is F or —OCH3:
- R6 is not F;
- when R6 is F:
- at least one of R2, R3, R4, and R5 is not H;
- when R3 and R5 are H:
- R11 is not cyclopropyl;
- and R12 is not cyclopropyl;
- when R9 is Cl, R1 is not an amide group;
- when B is nitrogen and A and D are carbon:
- R4 may not be —CN or
- when R7 is —CHF2 and R4 is
- then R4 does not have the absolute stereochemistry
- and
- wherein, when R8 is
- then the following provisos are in effect:
- when R4 is F:
- at least one of R2, R3, R5, and R6 is not H;
- R3 is not C(O)N(CH3)2;
- and R5 is not C(O)N(CH3)2;
- when R4 is Cl:
- at least one of R2, R3, R5, and R6 is not H;
- when R3 is F:
- R4 is not C(O)NHCH2CH2CH2CH3, C(O)N(CH3)2, C(O)NHCH2CH2CH3, or C(O)NHC(CH3)3;
- R4 is not C(O)NHCH2CH2CH2OH, C(O)NHCH(CH3)2, —CN, or
- R1 is not
- R5 is not
- R3 is not
- when R2 is F:
- R5 is not —C(O)NH2;
- when R2 is —CH3, R4 and R5 do not form a pyrazole with atoms at c and d;
- and
- when B is nitrogen, R3 and R4 do not form an optionally substituted imidazole with the atoms at b and c;
- and
- wherein, when R8 is
- then following provisos are in effect:
- R4 is not —CH3, —C(O)NHCH2CH2OH, —NHC(O)CH(CH3)2, or
- when R4 is C(O)NHCH3, at least one of R2, R3, R5, and R6 is not H;
- when R4 is —OCH3:
- R3 is not F or —CH3;
- and R5 is not F or —CH3;
- when R4 is
- R3 is not Cl;
- and R5 is not Cl;
- when R4 is —C(O)NHCH(CH3)2 or —C(O)N(CH2CH3)2:
- at least one of R3 and R5 is not H;
- R5 is not —C(O)NH2;
- and
- R6 is not —CF3, comprising:
- condensing a compound of formula V
- and a compound of formula VI
- to form a compound of formula XV
- reacting a compound of formula XV with a triflouromethylsulfonylation reagent to provide a compound of formula XVI
- and
- (1) reducing a compound of formula XVI to form a compound of formula XVII
- and subjecting a compound a formula XVII to Suzuki cross-coupling conditions with a boronate
- to form a compound of formula (I);
- or
- (2) subjecting a compound of formula XVI to Suzuki cross-coupling conditions with a boronate
- to form a compound of formula XIV
- and reducing a compound of formula XIV to form a compound of formula (I).
155 more elements
Dependencies are inferred from the claim text.